Introduction: A fragmentation pathway of atorvastatin de-protonated ion was proposed based on rational interpretation workflows. Method: The mass spectral data (MS, MS/MS and MS 3 ) of atorvastatin was obtained by electrospray negative ionization mode with flow injection analysis; using liquid chromatography systems coupled with tandem mass spectrometers (Q-trap and Q-ToF). Results: The fragmentation pathway was established using fragment ions of de-protonated ion; elemental composition, molecular structure and mechanism of formation for each major fragment presented. Pathway was proposed based on the MS 3 spectral data in combination with basic interpretation rules and rational workflows. Conclusion: This study and data interpretation workflows can be useful for writing fragmentation pathway, mechanism for formation of fragments, and can be applied for mass spectral data interpretation of similar small organic molecules.
Introduction
Mass spectrometry (MS) is an analytical technique/tool to identify and quantify verity of organic, inorganic and biological compounds. In pharmaceutical research and development, mass spectrometry plays a key role during development phases for all type of drug molecules: small organic molecules and large way for parent and product ions. A nitrogen-containing small organic molecule with hydroxyl, amide and carboxylic acid functional group atorvastatin was selected for this study and spectral data was generated using negative ion mode. Followed by prediction of fragmentation pathway of de-protonated ion, pathway of positive ion mode, i.e. protonated ion, was already published [14] .
Atorvastatin [15] [16] [17] is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme
A (HMG-CoA) reductase. This enzyme catalyzes the conversion of HMG-CoA to mevalonate, an early and rate-limiting step in cholesterol biosynthesis. It is used primarily as a lipid-lowering agent and for prevention of events associated with cardiovascular disease, especially people with Type 2 Diabetes, coronary heart disease, or other risk factors. It is an off-white crystalline powder and chemically known as (3R, 5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl] -3, 5-dihydroxyheptanoic acid. The empirical formula of atorvastatin calcium trihydrate is (C 33 H 34 FN 2 O 5 )2Ca•3H 2 O and its molecular weight is 1209.42. Atorvastatin free form empirical formula is C 33 H 35 FN 2 O 5 ; monoisotopic molecular weight is 558.2530 and molecular structure of atorvastatin free form is presented in Figure 1 .
During this study, mass spectral data of atorvastatin was generated using electrospray ionization and collision induced dissociation; followed by interpretation, workflow [18] and basic rules were used for the interpretation of the full scan atmospheric pressure ionization mass spectra (MS), collision induced dissociation fragmentation spectra (MS/MS) and MS 3 data.
Experimental

Drug Sample
Atorvastatin was extracted from generic dosage form. A final concentration was about 10 µg/ml in water, methanol and acetonitrile. was purchased from J.T. Baker.
Chemicals and Reagents
Instrumentation
Prominence 20 AD HPLC (Kyto Japan) and Waters Aquity HClass was coupled with Q-trap 5500 (AB SCIEX) and Xevo Q ToF mass spectrometer system respectively, equipped with electrospray ionization source (ESI) was used for this analysis.
Chromatographic and Mass Spectrometric Conditions
The extracted drug sample of atorvastatin was subjected to MS, MS/MS and MS 3 analysis via flow injection analysis (FIA) mode; liquid chromatography system was used to introduce the sample to mass spectrometer ion source. Liquid chromatography system set to isocratic flow 0.1 ml/min of mobile phase water and methanol in a ratio of 1:1 and injection volume was 10 µl. Electrospray ion source (negative ion mode) was selected to achieve the intense de-protonated parent ion and Q-trap mass analyzer selected to get the MS, MS/MS and MS
3
; which supported to predict the right fragmentation pathway. Spray voltage and collision energy optimized by using direct infusion mode to get optimum quality to spectral data. Experiments were acquired using optimized parameters; spray voltage of -4.0 kV for MS and collision energy (CE) setting of 40 V applied to generate MS/MS and MS 3 spectral data.
Results and Discussion
The experimental data (MS, MS/MS and MS Figure 2 .
Interpretation for these four fragments (F1, F2, F3 and F4) carried out and data presented in Figure 3 . Assigned molecular structures, elemental compositions and calculated molecular weight structures of MS/MS fragments were illustrated in Table 1 and Figure 3 ; pathways was assigned using MS/MS and MS spectral data of aforesaid product ions is present in Figures 8-11 . Interpretation of MS 3 spectral data was presented in Table 2 fragmentation pathway presented in Figure 12 & Figure 13 . Table 3 . 
Conclusion
This study and rational manual data interpretation workflow can be useful for writing fragmentation pathway, the mechanism for the formation of fragments, and can be applied for mass spectral data interpretation of small organic mole- Various software tools are available for the interpretation of mass spectrometry data; during the study, no software tool was used for interpretation, predication of the fragments structure and pathway of formation. In addition to above, the study also provides the insights about the in-depth structural analysis study for small organic molecules and manual workflow based interpretation of parent and product ion spectra in combination with the basic rules. The workflow ap- plied in this study was found efficient and can be applied to similar structure verification studies.
